NSCLC, NON-SMALL-CELL LUNG CARCINOMA
Clinical trials for NSCLC, NON-SMALL-CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NSCLC, NON-SMALL-CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for NSCLC, NON-SMALL-CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo targets hard-to-treat lung cancer in early trial
Disease control Not yet recruitingThis study tests a drug called firmonertinib combined with radiation therapy for people with stage III lung cancer that has specific genetic changes (EGFR uncommon mutations) and cannot be removed by surgery. The goal is to see if the combination can delay cancer growth or improv…
Matched conditions: NSCLC, NON-SMALL-CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated May 17, 2026 02:17 UTC
-
New hope for lung cancer patients with brain spread: targeted drug plus brain chemo
Disease control Not yet recruitingThis study tests a combination of a targeted drug (zorifertinib) and chemotherapy given directly into the fluid around the brain for people with a type of lung cancer that has spread to the lining of the brain. The goal is to control the disease and improve survival. About 38 adu…
Matched conditions: NSCLC, NON-SMALL-CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 13, 2026 16:03 UTC